25 episodes

Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer-reviewed proceedings of international meetings are featured. ARD is the official journal of EULAR.
* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

ARD Podcast BMJ Podcasts

    • Health & Fitness
    • 4.3 • 3 Ratings

Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer-reviewed proceedings of international meetings are featured. ARD is the official journal of EULAR.
* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

    Use of imaging in large vessel vasculitis: EULAR 2023 update

    Use of imaging in large vessel vasculitis: EULAR 2023 update

    Join our host Dr. Fabian Proft, ARD's Social Media Advisor, as he discusses the updated 2023 EULAR recommendations for imaging in large vessel vasculitis (LVV) with Professor Christian Dejaco and Dr. Milena Bond, the lead authors of the manuscript. This episode covers the latest evidence on ultrasound, MRI, CT, and FDG-PET for diagnosing and monitoring LVV.
    Key highlights include:
    Ultrasound as the first-line imaging test for giant cell arteritis.
    Preferred imaging modalities for Takayasu arteritis.
    Use of imaging for assessing vessel abnormalities and long-term monitoring.
    Insights into the research agenda for imaging in large vessel vasculitides.
    Tune in to learn how these updates aim to enhance patient care and stay informed on the latest developments in rheumatology imaging.Please subscribe to the ARD podcast on all podcast platforms, including Apple Podcast, Stitcher and Spotify. If you enjoy the show, feel free to leave us a comment or a review on the podcast iTunes page - https://podcasts.apple.com/gb/podcast/ard-podcast/id1171058059 .

    • 31 min
    Managing Systemic Lupus Erythematosus: the latest EULAR recommendations

    Managing Systemic Lupus Erythematosus: the latest EULAR recommendations

    This podcast brings you the 2023 update on the EULAR recommendations for the management of systemic lupus erythematosus (SLE).
    ARD's Social Media Advisor, Professor Laura Andreoli, speaks to Professors Antonios Fanouriakis and Dimitrios Boumpas, both from the "Attikon" University Hospital, National and Kapodistrian University of Athens, Greece, two of the authors of the recommendations paper. Read it on the ARD website: https://ard.bmj.com/content/83/1/15.
    Please subscribe to the ARD podcast on all podcast platforms, including Apple Podcast, Stitcher and Spotify. If you enjoy the show, feel free to leave us a comment or a review on the podcast iTunes page - https://podcasts.apple.com/gb/podcast/ard-podcast/id1171058059 .

    • 21 min
    A non-pharma approach in systemic lupus erythematosus and systemic sclerosis

    A non-pharma approach in systemic lupus erythematosus and systemic sclerosis

    In this podcast, we discuss the evidence-based EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc).ARD's Social Media Advisor, Professor Laura Andreoli, speaks to Professor Carina Boström and Professor Ioannis Parodis, both from the Karolinska Institutet and the Karolinska University Hospital, Stockholm, Sweden, about their recent paper. Read it on the ARD website: https://ard.bmj.com/content/early/2023/08/23/ard-2023-224416
    Please subscribe to the ARD podcast on all podcast platforms, including Apple Podcast, Google Podcasts, Stitcher and Spotify. If you enjoy the show, feel free to leave us a comment or a review on the podcast iTunes page -https://podcasts.apple.com/gb/podcast/ard-podcast/id1171058059 .
     

    • 18 min
    Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin

    Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin

    In this podcast, Dr. Truchetet discusses her work on the role of innate lymphoid cells in the fibrotic processes in systemic sclerosis (SSc) patients. The group of Dr. Truchetet found that ILC2 are crucial mediators of skin fibrosis in SSc and that combined treatment of patients with TGFb inhibitors and IL-10 might be an attractive new therapeutic approach in SSc.
    Read the full paper on the ARD website: https://ard.bmj.com/content/80/12/1594
    Please subscribe to the ARD podcast on all podcast platforms, including Apple Podcast, Google Podcasts, Stitcher and Spotify. If you enjoy the show, feel free to leave us a comment or a review on the podcast iTunes page (https://podcasts.apple.com/gb/podcast/ard-podcast/id1171058059).

    • 21 min
    Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

    Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

    In this podcast, we invite two authors from recent ARD papers dedicated to the efficacy of mRNA vaccines in patients with immunosuppressive therapies.
    Christophe Richez, Department of Rheumatology, University Medical Center, Bordeaux, France, and ARD's Social Media Advisor, interviews Bimba Hoyer, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Germany, and Rebecca H Haberman, Division of Rheumatology, University Grossman School of Medicine, New York, USA. They describe their works and offer their thoughts on the current situation in this area and the future.
    Related content:
    https://ard.bmj.com/content/early/2021/05/11/annrheumdis-2021-220272
    https://ard.bmj.com/content/early/2021/06/07/annrheumdis-2021-220597

    • 20 min
    The EULAR COVID-19 database and its insights into risk factors

    The EULAR COVID-19 database and its insights into risk factors

    The EULAR COVID-19 database and the COVID-19 Global Rheumatology Alliance work together on shared collected data to address the most pertinent questions in regard to risks for people with rheumatic diseases and COVID-19 infection. The latest study confirms already known risk factors for more severe disease and explores associations between treatments and the risk of death.
    In this podcast, ARD’s social media editor, Dr Paul Studenic, is joined by Prof. Pedro Machado, from the National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, London, UK, to discuss the paper “Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry” (http://dx.doi.org/10.1136/annrheumdis-2020-219498).

    • 25 min

Customer Reviews

4.3 out of 5
3 Ratings

3 Ratings

Top Podcasts In Health & Fitness

Huberman Lab
Scicomm Media
Nothing much happens: bedtime stories to help you sleep
iHeartPodcasts
Perform with Dr. Andy Galpin
Scicomm Media
On Purpose with Jay Shetty
iHeartPodcasts
The School of Greatness
Lewis Howes
Passion Struck with John R. Miles
John R. Miles

You Might Also Like

15 Minuten. Der tagesschau-Podcast am Morgen
tagesschau
NEJM This Week
NEJM Group
ACR on Air
American College of Rheumatology
LANZ & PRECHT
ZDF, Markus Lanz & Richard David Precht
ACR Journals On Air
American College of Rheumatology
Annals On Call Podcast
American College of Physicians